Search

everythinglearnresearchcommunity

for

Search:↓

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

ECCL should be considered in patients with specific skin and eye lesions.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

Older patients with new retinal lesions may have cancer, and local radiation might not stop it from spreading.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Eosinophilic pustular folliculitis should be considered in teens with persistent skin issues for accurate diagnosis and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

The 532 nm laser effectively reduces facial vascular and pigmented lesions, with the VISIA system reliably assessing treatment results.

Covid-19 worsens existing health issues and long-term effects are predictable.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

Certain drugs may cause vitiligo, so patients should be monitored.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

Long COVID affects about 27% of patients, with higher risk for women, lower education, and certain income levels.

Entospletinib effectively prevents eye and skin GVHD in mice.

A 78-year-old man with Cronkhite-Canada syndrome improved significantly after treatment and remains symptom-free.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

The young goat had anaplasmosis and copper deficiency.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.